
    
      Phase III, non-randomized, monocentric, observational, prospective trial. It is planned to
      recruit a total of 480 patients, including 240 patients receiving mastectomy with
      preservation of the nipple-areola complex and 240 patients with a reconstruction with
      latissimus dorsi flap, or in immediate reconstruction, or during secondary reconstruction.
    
  